PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmaceutics, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt.\', \'Department of Industrial & Physical Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA.\', \'Department of Biology, College of Science, United Arab Emirates University, Al Ain, United Arab Emirates.\', \'National Research Center for Protozoan Diseases, Obihiro University of Agriculture & Veterinary Medicine, Nishi 2-13, Inada-cho, Obihiro, Hokkaido, 080-8555, Japan.\', \'Department of Pharmacology & Therapeutics, Faculty of Veterinary Medicines, Damanhour University, Damanhour, 22511, Egypt.\', \'Department of Medical Microbiology & Immunology, Faculty of Medicine, Assiut University, Assiut, 71526, Egypt.\', \'Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0595, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2217/nnm-2020-0247
?:doi
?:hasPublicationType
?:journal
  • Nanomedicine (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32723142
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32723142>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32723142>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all